Company news
Wellbeing Digital Sciences Inc. (OTC:KONEF) news
Wellbeing Digital Sciences Inc. news releases on 6ix. Latest, Mar 3, 2022: Wellbeing Digital Sciences Subsidiary IRP Health Receives Approval From Veterans…
Press releases — page 2
Wellbeing Digital Sciences Subsidiary IRP Health Receives Approval From Veterans Affairs Canada for Reactivation Program
March 3, 2022
Wellbeing Digital Sciences Delivers its First IV Ketamine Treatment Under the Inpatient KITE Program
February 15, 2022
Wellbeing Digital Sciences Reveals Recent Achievements by Its KGK Science Subsidiary
February 2, 2022
Wellbeing Digital Sciences’ Subsidiary KGK Science Forms Tactical Partnership with Nova Mentis
January 27, 2022
Ketamine One Changes Name to Wellbeing Digital Sciences
January 24, 2022
OTC Markets Group Welcomes New OTCQB Companies – January 18
January 18, 2022
Ketamine One Becomes Exclusive Ketamine Treatment Provider to Victoria Wellness
January 17, 2022
Ketamine One Begins Trading on the OTCQB Marketplace on January 12, 2022
January 12, 2022
Ketamine One Subsidiary KGK Science Becomes the First Founding Sponsor of the “Psychedelic Science 2023” Event
January 10, 2022
Ketamine One Appoints Two New Members to Its Medical Advisory Board
January 5, 2022
Ketamine One Announces 2021 AGSM Results
December 19, 2021
Ketamine One Reports Audited Financial Results for the 2021 Fiscal Year
December 13, 2021
KetamineOne Adds Seattle Location to US Clinical Network
December 8, 2021
KetamineOne Subsidiary KGK Science Helps Client Receive New Dietary Ingredient Status from U.S. FDA
December 2, 2021
Ketamine One Partners with Cognetivity Neurosciences in Collaborative Clinical Study on Depression and PTSD
December 2, 2021
Ketamine One Provides Second Update on Management Cease Trade Order
November 29, 2021
Ketamine One Subsidiary IRP Health Opens Two New Veteran-Focused Clinics
November 16, 2021
Ketamine One Provides Update on Management Cease Trade Order
November 15, 2021
Ketamine One Announces Intention to Submit Draft Registration Statement for Proposed U.S. Initial Public Offering
November 9, 2021
Ketamine One Announces Resignation of Loreto Grimaldi From Board of Directors
November 4, 2021
Ketamine One Announces Virtual Mental Healthcare Platform in Partnership With iHealthOX
November 4, 2021
Ketamine One Announces Late Filing of Annual Financial Statements and Management Cease Trade Order
November 1, 2021
Ketamine One Provides Updated Information for Stock Exchange Listings
October 21, 2021
Ketamine One Features Biostrap as Part of Inaugural Research Studies
October 20, 2021